PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking (original) (raw)
Corona Virus (SARS-COV-2) Induced Inflammatory Lung Disease a Review on the Role of Renin–Angiotensin System and the Angiotensin Converting Enzyme-2
Sanjeev Arya
American Journal of Internal Medicine, 2020
View PDFchevron_right
Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expression
Po-Lan Su
Scientific Reports, 2023
View PDFchevron_right
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Arthur Slutsky
Nature Medicine, 2005
View PDFchevron_right
The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets
Zehra Edis
Journal of Biomolecular Structure and Dynamics
View PDFchevron_right
Smoking and COVID-19: Renin-Angiotensin System the Hidden Link
Amar Prasad Chaudhary
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES, 2020
View PDFchevron_right
Susceptibility of SARS-CoV-2 COVID-19 Infection among Smokers/Tobacco Users Upregulating the Expression of Angiotensin-Converting Enzyme-2 (ACE2
Maha Qasim
2022
View PDFchevron_right
Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts
Naresh Gaur
International Journal of Hypertension, 2020
View PDFchevron_right
Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients
Serge Camelo
Drug Discovery Today, 2021
View PDFchevron_right
Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers With COVID-19Pneumonia
Claudia Del Vecchio
Biomolecules
View PDFchevron_right
Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients With Comorbid Cardiovascular or Pulmonary Diseases
Research in Molecular Medicine (RMM)
View PDFchevron_right
Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
Marisa Brini
International Journal of Molecular Sciences
View PDFchevron_right
Renin–angiotensin system blockade in the COVID-19 pandemic
Hossam Shaltout
Ndt Plus, 2021
View PDFchevron_right
Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal
Keiji Tanimoto
Scientific Reports
View PDFchevron_right
The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials
Eugenie Forbes
Frontiers in Medicine, 2020
View PDFchevron_right
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
Fedor Simko
Clinical Science
View PDFchevron_right
Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?
Pawel Namsolleck
Molecular Medicine
View PDFchevron_right
Angiotensin Converting Enzyme 2 in COVID-19 infections and the implications of COVID-19 on major body systems
Chrystal Frank
Journal of Advances in Internal Medicine
View PDFchevron_right
Angiotensin converting enzyme 2 level and its significance in COVID‐19 and other diseases patients
Manali Dalvi
European Journal of Clinical Investigation
View PDFchevron_right
The Potential Role of ACEi and ARBs in COVID-19; A Perpsective
Ahmad Hassan
View PDFchevron_right
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Arthur Slutsky
Intensive Care Medicine, 2020
View PDFchevron_right
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
Kathryn Barnsley
Journal of Clinical Medicine, 2020
View PDFchevron_right
Angiotensin-Converting Enzyme 2 Roles in the Pathogenesis of COVID-19
tahereh safari
Current Hypertension Reviews, 2021
View PDFchevron_right
Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity
Zena Wehbe
Molecular Pharmacology, 2020
View PDFchevron_right
COVID-19 and renin-angiotensin system modulators: what do we know so far?
Jonathan Bella
Expert Review of Cardiovascular Therapy
View PDFchevron_right
The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19
Adeolu Adedapo, Ademola Oyagbemi, Veterinary World
Veterinary World, 2021
View PDFchevron_right
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
Ashwin Shukla
High Blood Pressure & Cardiovascular Prevention
View PDFchevron_right
Role of Angiotensin Converting Enzyme-2 and its modulation in disease: exploring new frontiers
Anup Bhat
Medicine and Pharmacy Reports, 2023
View PDFchevron_right
The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19
mauro cataldi
Frontiers in Physiology, 2021
View PDFchevron_right
The Potential Role of Renin Angiotensin System (RAS) and Dipeptidyl Peptidase-4 (DPP-4) in COVID-19: Navigating the Uncharted
Ali Al-Gareeb
Selected Chapters from the Renin-Angiotensin System, 2020
View PDFchevron_right
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
Jose Reyna
Circulation Research, 2020
View PDFchevron_right
Angiotensin-Converting-Enzyme 2 and SARS-CoV2: A Dangerous Liaison
adrian sturza
Timisoara Medical Journal, 2020
View PDFchevron_right
Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
Ricardo Stein
Clinics
View PDFchevron_right
Hypertension and chronic obstructive pulmonary disease – current challenges during the COVID-19 pandemic
octavian istratoaie
2020
View PDFchevron_right